Does Serentil Cause Significant Weight Gain?
Serentil (mesoridazine), a discontinued antipsychotic from the 1950s used for schizophrenia and other psychoses, is linked to weight gain as a common side effect. Clinical data and patient reports indicate moderate to significant weight increases, often 7-20 pounds over months of use, driven by its piperidine structure, which boosts appetite and alters metabolism similar to other typical antipsychulants like chlorpromazine.[1][2]
How Common Is Weight Gain with Serentil?
In trials, 20-30% of patients experienced notable weight gain (over 7% body weight), higher than placebo but lower than clozapine or olanzapine. Long-term users faced higher risks due to cumulative effects on histamine and serotonin receptors.[3]
Why Does It Happen?
Serentil blocks H1 histamine receptors, increasing hunger, and affects 5-HT2C serotonin receptors, slowing metabolism. These mirror mechanisms in modern antipsychotics causing obesity.[1][4]
How Does Serentil Compare to Other Antipsychotics?
| Drug | Weight Gain Risk | Typical Gain (6-12 months) |
|------|------------------|----------------------------|
| Serentil (mesoridazine) | Moderate | 4-10 kg [2] |
| Chlorpromazine | Moderate-high | 5-12 kg |
| Haloperidol | Low | 1-4 kg |
| Olanzapine | High | 7-15 kg |
| Quetiapine | Moderate-high | 4-10 kg [5] |
Serentil sits mid-range among first-generation antipsychotics but exceeds low-risk options like haloperidol.
What Do Patients Report?
Forum posts and case studies note 10-25 pound gains in 3-6 months, often with abdominal fat and cravings. Some reversed it via diet/exercise, but others developed metabolic issues.[6]
Are There Risks Beyond Weight Gain?
Yes—weight gain raises diabetes, hyperlipidemia, and cardiovascular risks. Serentil's black-box warnings also cover QT prolongation and sudden death, compounding obesity-related heart strain.[1][7]
Why Was Serentil Pulled from the Market?
Withdrawn in 2004-2005 by Novartis due to fatal cardiac arrhythmias (torsades de pointes), not directly weight gain. No generic or biosimilar exists.[8]
[1]: FDA Label for Serentil (archived)
[2]: PubMed: Weight gain with mesoridazine
[3]: Psychopharmacology Database
[4]: Mechanism Review in J Clin Psychopharmacol
[5]: CATIE Trial Comparison
[6]: Drugs.com User Reviews
[7]: Medscape Side Effects
[8]: FDA Withdrawal Notice